Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Sufferers ought to contemplate creating private overviews to assist care groups see them as people, defined Michelle Kirschner.In an interview with CURE, Kirschner...
A possible new first-line remedy possibility for sufferers with metastatic HER2-positive breast most cancers was highlighted by Dr. Sara M. Tolaney through the...
